Skip to content

The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles

A Prospective Observational Study of the Impact of a Recent Past COVID-19 Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05739019
Enrollment
820
Registered
2023-02-22
Start date
2023-02-23
Completion date
2025-02-01
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Frozen Embryo Transfer

Brief summary

This is a prospective observational study. In this study, we aim to investigate the effect of a recent past Covid-19 infection on the live birth rate in the frozen embryo transfer cycles

Interventions

OTHERfrozen embryo transfer

transfer one or two embryos in frozen embryo transfer cycles

Sponsors

ShangHai Ji Ai Genetics & IVF Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

1. Women aged 20-42 years at the time of ovarian stimulation for in vitro fertilization 2. Women have embryos frozen prior to COVID infection.

Exclusion criteria

1. Previous COVID infection before oocyte retrieval 2. Recipient of oocyte donation 3. Undergoing preimplantation genetic testing 4. Presence of hydrosalpinx or endometrial polyp which is not surgically treated

Design outcomes

Primary

MeasureTime frameDescription
live birth ratea live birth after 22 weeks gestationlive birth rate of the frozen embryo transfer cycle (\>22 weeks of gestation)

Secondary

MeasureTime frameDescription
clinical pregnancypresence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancypresence of intrauterine gestational sac on ultrasound
ongoing pregnancyviable pregnancy beyond gestation 12 weeksviable pregnancy beyond gestation 12 weeks
biochemical pregnancypositive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestationpositive blood pregnancy test not followed by clinical pregnancy
implantation ratenumber of gestational sacs per embryo transferred during 4 weeks of pregnancynumber of gestational sacs per embryo transferred
serum hCG levela blood pregnancy test is performed 14 days after the embryo transferserum hCG level
ectopic pregnancyectopic pregnancy during 12 weeks gestationpregnancy outside the uterine cavity
miscarriagethe loss of a pregnancy before 22 weeks gestationthe loss of a pregnancy before 22 weeks gestation
birth weighta live birth after 22 weeks gestationbirth weight of the baby delivered
serum COVID-19 antibody level7 days before embryo transferserum COVID-19 antibody level immunoglobulin G and immunoglobulin M
multiple pregnancymultiple pregnancy beyond gestation 12 weeksmore than one intrauterine sacs on scanning

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026